Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties

Curr Drug Metab. 2015;16(5):389-96. doi: 10.2174/1389200215666141125121211.

Abstract

During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / administration & dosage
  • Delayed-Action Preparations
  • Drug Delivery Systems*
  • Genetic Therapy / methods
  • Humans
  • Nanoparticles*
  • Nanotechnology / methods*
  • Nanotechnology / trends
  • Neoplasms / diagnosis
  • Neoplasms / therapy
  • Neurodegenerative Diseases / diagnosis
  • Neurodegenerative Diseases / therapy
  • Polymers / chemistry

Substances

  • Biocompatible Materials
  • Delayed-Action Preparations
  • Polymers